Corlanor® was added to the chronic heart failure treatments of patients who had:
- Symptoms of heart failure that were stable
- Reduced function in lower-left part of the heart
- Resting heart rate of 70 beats per minute or higher
- A prior hospital stay for heart failure in the past year
These patients were monitored for nearly 2 years.
Corlanor® was proven to reduce their chances of hospitalization from chronic heart failure, compared to people who were given sugar pills (placebo).